supported by strong scientific validation and intellectual property. By integrating advanced research, biotechnology, and nature-based innovation, Ages develops exclusive synergistic combinations that go beyond conventional wellness products. Its portfolio is designed to address the largest and most persistent health demands related to aging and chronic conditions, where long-term, evidence-based interventions are increasingly critical. Ages’ innovation platform combines deep R&D capabilities with strong execution and market adoption. Alongside its scientific development, the company operates an active commercialization strategy that accelerates product adoption through healthcare professionals, clinical education, and real-world application. Its nutraceuticals are already in use, generating revenue and clinical experience that continuously feeds back into product refinement and pipeline expansion. Founded in Brazil, Ages has achieved consistent growth while building a recognized brand and scientific reputation in the nutraceutical sector. With proprietary assets, scalable synergistic compounds, and a clear international vision, Ages Bioactive is positioned to become a global reference in therapeutic-grade nutraceuticals—connecting science, nature, and technology to redefine healthy aging and longevity.